Processa Pharmaceuticals, Inc.
Company Stats
- Market Cap
- $4.6M
- as of Sep 30, 2026
- Shares Outstanding
- 2.8M
- Free Float
- 25.2%
Income Statement
- Operating Income
- -$14.0M
- Net Income
- -$13.6M
- EBITDA
- -$14.0M
Balance Sheet
- Cash & Equivalents
- $5.5M
Returns & Capital
- SBC, 3Y Avg
- $849,134
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2024 | — | -$11.2M | — |
| FY2023 | — | -$8.1M | — |
| FY2022 | $0 | — | — |
| FY2021 | $0 | — | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 12, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Simon Property Group Directors Lead Weekly Buying Surge